What is Enovis's SG&A?

Enovis (ENOV) reported SG&A of $282.81M in Q1 2026.

How has Enovis's SG&A changed year-over-year?

Enovis's SG&A increased by 5.1% year-over-year, from $269.02M to $282.81M.

What is the long-term trend for Enovis's SG&A?

Over 4 years (2021 to 2025), Enovis's SG&A has grown at a 5.9% compound annual growth rate (CAGR), from $850.46M to $1.07B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Enovis ENOV SG&A

SG&A at other companies

Johnson & JohnsonJNJ

$6.03B+18.0%

StrykerSYK

$2.28B-0.8%

Zimmer Biomet HoldingsZBH

$849.9M+12.0%

ESABESAB

$174.47M+23.9%

VericelVCEL

$49.23M+17.8%

CONMEDCNMD

$141.7M-4.8%

Other financials

Income statement

See full

Revenue$589.2M+5.4%

Gross profit$365.5M+10.0%

Operating income$6.5M+114%

Net income-$8.8M+84.3%

EPS (diluted)-$0.15+84.7%

Balance sheet

See full

Cash & equivalents$33.1M-13.9%

Total debt$1.4B-3.1%

Total equity$1.5B-43.6%

Total assets$3.8B-21.4%

Cash flow

See full

Operating cash flow$24.0M+1,601%

CapEx$52.8M+22.1%

Free cash flow-$28.9M+35.7%

Valuation

See full

Market cap$1.23B-28.4%

Enterprise value$2.55B-17.1%

P/S0.5×-0.3×

Profitability

See full

Gross margin60.5%+4.0pp

Operating margin-47%+18.6pp

Net margin-49.9%+24.1pp

FCF margin-3.1%-1.1pp

Returns & leverage

See full

Return on equity-55.5%-1,722pp

Debt / equity0.9×+0.4×

Current ratio2×-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Enovis's SG&A?: Enovis (ENOV) reported SG&A of $282.81M in Q1 2026.
How has Enovis's SG&A changed year-over-year?: Enovis's SG&A increased by 5.1% year-over-year, from $269.02M to $282.81M.
What is the long-term trend for Enovis's SG&A?: Over 4 years (2021 to 2025), Enovis's SG&A has grown at a 5.9% compound annual growth rate (CAGR), from $850.46M to $1.07B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.